Title: Excipient Risk Assessment as per the EU Guidance and SMARTRISK as a solution
Date: 1 December 2020
Time: 3PM CET
Duration: 1 hour
- Gain an understanding of the full requirements for Excipient Risk Assessment as per EU Guidelines of 19th March 2015 on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use
- Where does the Excipient Risk Assessment sit in your overall Quality Risk Management plan?
- How does SMARTRISK provide a solution for compliance with the requirement for an Excipient Risk Assessment
Director/Senior Consultant, Quality and Compliance, PharmaLex